Buchumschlag

Comparative utcomes of neoadjuvant treatment prior to total mesorectal excision and total mesorectal excision alone in selected stage II/III low and mid rectal cancer

Current guidelines advocate that all rectal cancer patients with American Joint Committee on Cancer (AJCC) stages II and III disease should be subjected to neoadjuvant therapy. However, improvements in surgical technique have resulted in single-digit local recurrence rates with surgery only.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kulu, Yakup (VerfasserIn) , Tarantino, Ignazio (VerfasserIn) , Billeter, Adrian (VerfasserIn) , Diener, Markus K. (VerfasserIn) , Schmidt, Thomas (VerfasserIn) , Büchler, Markus W. (VerfasserIn) , Ulrich, Alexis (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2016
In: Annals of surgical oncology
Year: 2016, Jahrgang: 23, Heft: 1, Pages: 106-113
ISSN:1534-4681
DOI:10.1245/s10434-015-4832-5
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1245/s10434-015-4832-5
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1245%2Fs10434-015-4832-5
Volltext
Verfasserangaben:Yakup Kulu, Ignazio Tarantino, Adrian T. Billeter, Markus K. Diener, Thomas Schmidt, Markus W. Büchler, and Alexis Ulrich
Beschreibung
Zusammenfassung:Current guidelines advocate that all rectal cancer patients with American Joint Committee on Cancer (AJCC) stages II and III disease should be subjected to neoadjuvant therapy. However, improvements in surgical technique have resulted in single-digit local recurrence rates with surgery only.
Beschreibung:Online veröffentlicht: 25. August 2015
Gesehen am 02.06.2020
Beschreibung:Online Resource
ISSN:1534-4681
DOI:10.1245/s10434-015-4832-5

Ähnliche Einträge